- Report
- September 2026
- 183 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 191 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 192 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 189 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 184 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 191 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 181 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 198 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 190 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 196 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 192 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 184 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- September 2026
- 185 Pages
Global
From €3197EUR$3,545USD£2,742GBP
€3552EUR$3,939USD£3,046GBP
- Report
- June 2026
- 209 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- August 2026
- 151 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- July 2026
- 575 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- July 2026
- 207 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- June 2026
- 77 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- March 2026
- 235 Pages
Global
From €4328EUR$4,799USD£3,711GBP
- Report
- December 2025
- 473 Pages
Global
From €4328EUR$4,799USD£3,711GBP

The Peptide market is a subset of the biopharmaceutical industry, which focuses on the development and production of therapeutic proteins and peptides. Peptides are short chains of amino acids that are used to treat a variety of diseases, including cancer, diabetes, and autoimmune disorders. Peptides are typically produced through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein.
The Peptide market is highly competitive, with a number of companies offering a variety of products. Companies in the market are focused on developing and manufacturing peptides for therapeutic use, as well as providing services such as peptide synthesis and purification. Additionally, some companies are involved in the development of peptide-based drug delivery systems.
Notable companies in the Peptide market include Novo Nordisk, Merck, Sanofi, and Pfizer. Other companies include AbbVie, Amgen, and Genentech. Show Less Read more